The 2025 Conference on High Quality Development of Innovative Drugs was held in Guangzhou on the morning of December 7th. The conference will release the 2025 National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog and the first edition of the Commercial Health Insurance Innovative Drug Catalog

It is reported that the 2025 National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog is the 8th adjustment since the establishment of the National Medical Insurance Bureau. This directory adjustment adds 114 new drugs, of which 50 are Class 1 innovative drugs. The first edition of the commercial insurance innovative drug catalog includes a total of 19 drugs, including cancer treatment drugs such as CAR-T, as well as Alzheimer's disease treatment drugs with high social attention.